Skip to content
healthcare.dev

Ceftazidime

NDC 25021-129, ceftazidime, injection, powder, for solution, from Sagent Pharmaceuticals.

Product NDC
25021-129
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA062640
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-129 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEFTAZIDIME6 g/30mL

Pharmacologic classes

Cephalosporin Antibacterial [EPC]; Cephalosporins [CS]

Package NDCNDC-11Package
25021-129-99250210129996 BOTTLE in 1 CARTON (25021-129-99) / 30 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aec64360-8452-4987-a366-a5a4f8762ab6
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-129

Use it

Look up 25021-129 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-129 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-129. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.